Hsu-Ching Huang

Phase III KEYNOTE-789 Study of Pemetrexed and Platinum With or Without Pembrolizumab for Tyrosine Kinase Inhibitor‒Resistant, <i>EGFR</i> –Mutant, Metastatic Nonsquamous Non–Small Cell Lung Cancer

James Chih‐Hsin Yang, Dae Ho Lee, Jong‐Seok Lee et al. · Journal of Clinical Oncology · 2024 · 142 citations · Full text

Medicine, Oncology, Pharmacology +14

Radiation recall pneumonitis induced by epidermal growth factor receptor-tyrosine kinase inhibitor in patients with advanced nonsmall-cell lung cancer

Chi‐Lu Chiang, Yi‐Wei Chen, Mei‐Han Wu et al. · Journal of the Chinese Medical Association · 2016 · 43 citations

Medicine, Oncology, Pharmacology +13

Real-world evidence of the intrinsic limitations of PCR-based EGFR mutation assay in non-small cell lung cancer

Chia‐I Shen, Chi‐Lu Chiang, Tsu‐Hui Shiao et al. · Scientific Reports · 2022 · 41 citations · Full text

Medicine, Molecular Biology, Oncology +17

Lung Adenocarcinoma with Ipsilateral Breast Metastasis: A Simple Coincidence?

Hsu-Ching Huang, Jen‐Fan Hang, Mei‐Han Wu et al. · Journal of Thoracic Oncology · 2013 · 26 citations · Full text

Medicine, Oncology, Surgery +13

Comparison of the outcome between immunotherapy alone or in combination with chemotherapy in EGFR-mutant non-small cell lung cancer

Chia‐I Shen, Heng‐Sheng Chao, Tsu‐Hui Shiao et al. · Scientific Reports · 2021 · 23 citations · Full text

Medicine, Oncology, Chemotherapy +13